Загрузка...
TLR9 and MyD88 are crucial for the maturation and activation of dendritic cells by paromomycin–miltefosine combination therapy in visceral leishmaniasis
BACKGROUND AND PURPOSE: The combination of paromomycin–miltefosine is a successful anti-leishmanial therapy in visceral leishmaniasis (VL). This encouraged us to study its effect on Toll-like receptor (TLR)-mediated immunomodulation of dendritic cells (DC), as DC maturation and activation is crucial...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Blackwell Publishing Ltd
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3952803/ https://ncbi.nlm.nih.gov/pubmed/24670148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.12530 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|